Pharmaceutical Industry Information Portal

HomeExpert Articles

Expert Articles

Top biopharma companies could be affected by Brazilian drug patent suspension

GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.

AI and big data will continue to disrupt pharmaceutical sector

AI and big data have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes.

GMP-Inspections of foreign veterinary manufacturers in the first half of 2021

This review contains the latest information related to inspection of manufacturers of veterinary medicinal products manufactured outside the Russian Federation for compliance with the...

The global API market is expected to reach approximately $300 billion by 2030

The global active pharmaceutical ingredient market stood at around $190 billion in 2020, and it is expected to reach approximately $300 billion by 2030....

Microgen has increased the export of medicinal products to Uzbekistan

For the first quarter of 2021 NPO Microgen, managed by the Nacimbio holding of the Rostec State Corporation, has increased the export of medicinal...
spot_img

Latest News

spot_img